Kraig Biocraft Laboratories, Inc.

203 articles with Kraig Biocraft Laboratories, Inc.

• Kraig Biocraft Laboratories Completes Installation of Automated Production Equipment

  6/23/2021

  Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that it has completed the installation of automated mulberry processing equipment at its factory in Vietnam.

• Kraig Biocraft Laboratories Transfers Onsite Testing and Screening of Transgenics Technology to its Prodigy subsidiary

  6/7/2021

  Equipment transfer positions Prodigy to expedite production expansion and next-generation disease-resistant silkworms

• Kraig Biocraft Laboratories Strengthens Production Operations with New Automated EquipmentNew Automated Equipment to expand and expedite Silk Processing

  6/1/2021

  Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces considerable investments in strengthening its Vietnam based production operations.

• Kraig Biocraft Laboratories Celebrates Arbor Day by Funding Planting of more than 100,000 Mulberry Trees

  4/30/2021

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, honors Arbor Day by funding the planting of more than 100,000 mulberry trees.  

• Kraig Biocraft Laboratories subsidiary, Spydasilk Enterprises, files for registration of multiple Spider Silk brand trademarks

  4/22/2021

  Kings Group, Kraig’s joint venture partner, leads branding, with unique trademarks centered on spider silk

• Kraig Biocraft Laboratories and Kings Group form Spydasilk Enterprises Pte. Ltd., a Singapore based Joint Venture Company, for the marketing and sales of spider silk based products

  4/9/2021

  Kraig’s joint venture with Kings is tied to the previously announced exclusive spider silk purchase and sales agreement valued at up to US$40 million

• Kraig Biocraft Laboratories Secures $4 Million Dollars of Expansion Capital

  3/26/2021

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced today that it has secured $4 million dollars of expansion capital. This financing significantly strengthens the Company’s balance sheet and supports its progress in the commercialization and sale of recombinant spider silk.

• Kraig Biocraft Laboratories Announces Expanded Spider Silk Protection with Patent Granted in Vietnam

  3/15/2021

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that the University of Notre Dame has been granted a Vietnamese patent on spider silk technology developed pursuant to the collaborative research agreement with Kraig .

• Kraig Biocraft Laboratories Increases Planned Production by Doubling Near Term Spider Silk Production Schedule

  3/10/2021

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the Company has doubled its planned production volumes of its recombinant spider silk for the month of March.

• Kraig Biocraft Laboratories Announces Spider Silk Patent Granted in Canada

  3/2/2021

  Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that the University of Notre Dame has been granted a Canadian patent on spider silk technology developed pursuant to the collaborative research agreement with Kraig.

• Kraig Biocraft Laboratories receives its first-ever Spider Silk shipment from its Vietnamese production facilityProdigy Textiles reaches major milestone delivering first fibers to Company Headquarters

  2/23/2021

  Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that the Company received its first small shipment of spider silk from Prodigy textiles, its wholly-owned Vietnamese subsidiary.

• Kraig Biocraft Laboratories files for International Patents in Key Spider Silk Knock-in Knock-out Technology

  2/16/2021

  Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that the Company has filed a patent application protecting its most advanced knock-in knock-out gene editing technologies for the creation of nearly pure spider silk.

• Kraig Biocraft Laboratories and MtheMovement by Kings Group sign Exclusive Purchase and Sales Agreement for up to potentially $40 million

  1/26/2021

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that it is forming a joint venture partnership with MtheMovement, an eco-friendly luxury streetwear apparel line, part of the Kings Group of Companies and its affiliated companies (“Kings Group”).

• Kraig Biocraft Laboratories Secures Bridge Funding and Files to Become Fully Reporting Company

  12/11/2020

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced today that it has secured $950,000 in bridge financing and simultaneously filed with the SEC to become a mandatory, fully reporting company.

• Kraig Biocraft Laboratories Delivers Recombinant Spider Silk Silkworm Eggs to Production Facility in Vietnam

  10/28/2020

  Kraig Biocraft Laboratories, Inc., announces that it has delivered its latest batch of spider silk silkworm eggs to its production facility in Vietnam.

• Kraig Biocraft Laboratories Completes Production of Silkworm Eggs for Spider Silk Production

  10/15/2020

  Kraig Biocraft Laboratories, Inc., announces that it has completed production and genetic screening of its latest batch of spider silk silkworm eggs.

• Kraig Biocraft Laboratories tackles biggest challenge facing Global Silk Production

  6/29/2020

  Kraig Biocraft Laboratories, Inc., a leading developer of spider silk based fibers, announces that it has completed the development phase of a new program targeting the largest challenge facing global silk production, viral pathogens.

• Kraig Biocraft Laboratories files Application for Up-listing to the Nasdaq Capital Market

  6/9/2020

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), a leading developer of spider silk based fibers, announces that it has submitted its formal application to list the Company’s common stock on the Nasdaq Capital Market. “After significantly strengthening our technology, business model, and corporate governance, to position Kraig Labs for future growth, an uplisting to the Nasdaq Capital Market is the natural evolution for the Comp

• Kraig Biocraft Laboratories Holds First Meeting of Board of Directors Elect

  5/18/2020

  Kraig Biocraft Laboratories, Inc. announces that the Company’s Board of Directors held its first meeting with its four new members-elect in attendance.

• Kraig Biocraft Laboratories Prepares for 2020 Production

  5/12/2020

  Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”) announces that Company is preparing to transfer production back to Prodigy Textiles, its Vietnamese subsidiary.  During the COVID-19 lockdown, when the Company opted to furlough its non-essential staff, the Company shifted its spider silk production operations focus to its US research facility.  The Company is now ready to transition the majority of its production back to Vietnam